Industry Growth Insights published a new data on “Biologic Therapeutics Market”. The research report is titled “Biologic Therapeutics Market research by Types (Vaccines, Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Protein, Cellular Therapies, Xenotransplantation Products), By Applications (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Players/Companies Pfizer, Novartis Global, AstraZeneca, Merck, GlaxoSmithKline, Aurobindo Pharma”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biologic Therapeutics Market Research Report
By Type
Vaccines, Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Protein, Cellular Therapies, Xenotransplantation Products
By Application
Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others
By Companies
Pfizer, Novartis Global, AstraZeneca, Merck, GlaxoSmithKline, Aurobindo Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Biologic Therapeutics Market Report Segments:
The global Biologic Therapeutics market is segmented on the basis of:
Types
Vaccines, Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Protein, Cellular Therapies, Xenotransplantation Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis Global
- AstraZeneca
- Merck
- GlaxoSmithKline
- Aurobindo Pharma
Highlights of The Biologic Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vaccines
- Blood Products
- Allergenic Extracts
- Human Cells and Tissues
- Gene Therapies
- Protein
- Cellular Therapies
- Xenotransplantation Products
- By Application:
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biologic Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biologic Therapeutics is a field of medicine that uses biological agents to treat diseases. These agents can be viruses, bacteria, or other types of cells.
Some of the major players in the biologic therapeutics market are Pfizer, Novartis Global, AstraZeneca, Merck, GlaxoSmithKline, Aurobindo Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biologic Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biologic Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biologic Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biologic Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biologic Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Biologic Therapeutics Market Size and Y-o-Y Growth
4.5.2 Biologic Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Biologic Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biologic Therapeutics Market Size Forecast by Type
5.2.1 Vaccines
5.2.2 Blood Products
5.2.3 Allergenic Extracts
5.2.4 Human Cells and Tissues
5.2.5 Gene Therapies
5.2.6 Protein
5.2.7 Cellular Therapies
5.2.8 Xenotransplantation Products
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biologic Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biologic Therapeutics Market Size Forecast by Applications
6.2.1 Rheumatoid Arthritis
6.2.2 Anemia
6.2.3 Cancer
6.2.4 Diabetes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biologic Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biologic Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biologic Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Biologic Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biologic Therapeutics Market Size Forecast by Type
9.6.1 Vaccines
9.6.2 Blood Products
9.6.3 Allergenic Extracts
9.6.4 Human Cells and Tissues
9.6.5 Gene Therapies
9.6.6 Protein
9.6.7 Cellular Therapies
9.6.8 Xenotransplantation Products
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biologic Therapeutics Market Size Forecast by Applications
9.10.1 Rheumatoid Arthritis
9.10.2 Anemia
9.10.3 Cancer
9.10.4 Diabetes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biologic Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Biologic Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biologic Therapeutics Market Size Forecast by Type
10.6.1 Vaccines
10.6.2 Blood Products
10.6.3 Allergenic Extracts
10.6.4 Human Cells and Tissues
10.6.5 Gene Therapies
10.6.6 Protein
10.6.7 Cellular Therapies
10.6.8 Xenotransplantation Products
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biologic Therapeutics Market Size Forecast by Applications
10.10.1 Rheumatoid Arthritis
10.10.2 Anemia
10.10.3 Cancer
10.10.4 Diabetes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biologic Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biologic Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biologic Therapeutics Market Size Forecast by Type
11.6.1 Vaccines
11.6.2 Blood Products
11.6.3 Allergenic Extracts
11.6.4 Human Cells and Tissues
11.6.5 Gene Therapies
11.6.6 Protein
11.6.7 Cellular Therapies
11.6.8 Xenotransplantation Products
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biologic Therapeutics Market Size Forecast by Applications
11.10.1 Rheumatoid Arthritis
11.10.2 Anemia
11.10.3 Cancer
11.10.4 Diabetes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biologic Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Biologic Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biologic Therapeutics Market Size Forecast by Type
12.6.1 Vaccines
12.6.2 Blood Products
12.6.3 Allergenic Extracts
12.6.4 Human Cells and Tissues
12.6.5 Gene Therapies
12.6.6 Protein
12.6.7 Cellular Therapies
12.6.8 Xenotransplantation Products
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biologic Therapeutics Market Size Forecast by Applications
12.10.1 Rheumatoid Arthritis
12.10.2 Anemia
12.10.3 Cancer
12.10.4 Diabetes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biologic Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biologic Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biologic Therapeutics Market Size Forecast by Type
13.6.1 Vaccines
13.6.2 Blood Products
13.6.3 Allergenic Extracts
13.6.4 Human Cells and Tissues
13.6.5 Gene Therapies
13.6.6 Protein
13.6.7 Cellular Therapies
13.6.8 Xenotransplantation Products
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biologic Therapeutics Market Size Forecast by Applications
13.10.1 Rheumatoid Arthritis
13.10.2 Anemia
13.10.3 Cancer
13.10.4 Diabetes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biologic Therapeutics Market: Competitive Dashboard
14.2 Global Biologic Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis Global
14.3.3 AstraZeneca
14.3.4 Merck
14.3.5 GlaxoSmithKline
14.3.6 Aurobindo Pharma
